UA123763C2 - Фармацевтична композиція для контролю або лікування захворювання або порушення, пов’язаного з fgf19 - Google Patents

Info

Publication number

UA123763C2

UA123763C2 UAA201703593A UAA201703593A UA123763C2 UA 123763 C2 UA123763 C2 UA 123763C2 UA A201703593 A UAA201703593 A UA A201703593A UA A201703593 A UAA201703593 A UA A201703593A UA 123763 C2 UA123763 C2 UA 123763C2

Authority

UA

Ukraine

Prior art keywords

bek

beh

niv

aza

uvi

Prior art date

2014-10-23

Links

• Espacenet
• Global Dossier
• Discuss

• 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 276
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 169
• 201000010099 disease Diseases 0.000 title claims description 98
• 238000011282 treatment Methods 0.000 title claims description 20
• 102100031734 Fibroblast growth factor 19 Human genes 0.000 title abstract description 7
• 101000846394 Homo sapiens Fibroblast growth factor 19 Proteins 0.000 title 1
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 742
• 238000000034 method Methods 0.000 claims abstract description 82
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 70
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 64
• 235000001014 amino acid Nutrition 0.000 claims description 394
• 150000001413 amino acids Chemical class 0.000 claims description 314
• 229940024606 amino acid Drugs 0.000 claims description 310
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 83
• 238000002360 preparation method Methods 0.000 claims description 76
• 208000035475 disorder Diseases 0.000 claims description 70
• 206010028980 Neoplasm Diseases 0.000 claims description 64
• 239000000872 buffer Substances 0.000 claims description 62
• 235000018102 proteins Nutrition 0.000 claims description 60
• 239000000203 mixture Substances 0.000 claims description 57
• HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 51
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 51
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 50
• 239000003613 bile acid Substances 0.000 claims description 45
• HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims description 43
• 230000000694 effects Effects 0.000 claims description 40
• 125000000539 amino acid group Chemical group 0.000 claims description 39
• 230000013632 homeostatic process Effects 0.000 claims description 36
• 239000003814 drug Substances 0.000 claims description 34
• 229940079593 drug Drugs 0.000 claims description 31
• 201000011510 cancer Diseases 0.000 claims description 29
• 235000013305 food Nutrition 0.000 claims description 28
• 238000004128 high performance liquid chromatography Methods 0.000 claims description 28
• IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 claims description 24
• 239000003937 drug carrier Substances 0.000 claims description 23
• 210000001508 eye Anatomy 0.000 claims description 22
• 230000009471 action Effects 0.000 claims description 20
• 239000011780 sodium chloride Substances 0.000 claims description 20
• 239000000243 solution Substances 0.000 claims description 19
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 18
• 229910052740 iodine Inorganic materials 0.000 claims description 18
• 230000004048 modification Effects 0.000 claims description 18
• 238000012986 modification Methods 0.000 claims description 18
• 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 18
• 230000015572 biosynthetic process Effects 0.000 claims description 17
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 16
• 208000024891 symptom Diseases 0.000 claims description 16
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
• 238000004458 analytical method Methods 0.000 claims description 15
• 229920001213 Polysorbate 20 Polymers 0.000 claims description 14
• 239000007924 injection Substances 0.000 claims description 14
• 238000002347 injection Methods 0.000 claims description 14
• 239000007788 liquid Substances 0.000 claims description 14
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 14
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 14
• 208000001145 Metabolic Syndrome Diseases 0.000 claims description 13
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 13
• 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims description 13
• 229940068977 polysorbate 20 Drugs 0.000 claims description 13
• 206010018429 Glucose tolerance impaired Diseases 0.000 claims description 12
• 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 12
• 230000003345 hyperglycaemic effect Effects 0.000 claims description 12
• 206010008635 Cholestasis Diseases 0.000 claims description 11
• 230000009102 absorption Effects 0.000 claims description 11
• 238000010521 absorption reaction Methods 0.000 claims description 11
• 230000007870 cholestasis Effects 0.000 claims description 11
• 231100000359 cholestasis Toxicity 0.000 claims description 11
• 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 11
• 230000001965 increasing effect Effects 0.000 claims description 11
• 208000030159 metabolic disease Diseases 0.000 claims description 11
• 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims description 11
• 206010012735 Diarrhoea Diseases 0.000 claims description 10
• 206010060378 Hyperinsulinaemia Diseases 0.000 claims description 10
• 208000029742 colonic neoplasm Diseases 0.000 claims description 10
• 206010012601 diabetes mellitus Diseases 0.000 claims description 10
• 230000003451 hyperinsulinaemic effect Effects 0.000 claims description 10
• 201000008980 hyperinsulinism Diseases 0.000 claims description 10
• 239000000126 substance Substances 0.000 claims description 10
• 238000012360 testing method Methods 0.000 claims description 10
• 230000000007 visual effect Effects 0.000 claims description 10
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims description 9
• 208000033222 Biliary cirrhosis primary Diseases 0.000 claims description 9
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
• 206010022489 Insulin Resistance Diseases 0.000 claims description 9
• 208000012654 Primary biliary cholangitis Diseases 0.000 claims description 9
• 235000012000 cholesterol Nutrition 0.000 claims description 9
• 239000002773 nucleotide Substances 0.000 claims description 9
• 208000011580 syndromic disease Diseases 0.000 claims description 9
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
• 201000002531 Karyomegalic interstitial nephritis Diseases 0.000 claims description 8
• 238000003556 assay Methods 0.000 claims description 8
• 210000000013 bile duct Anatomy 0.000 claims description 8
• 208000020832 chronic kidney disease Diseases 0.000 claims description 8
• 208000019425 cirrhosis of liver Diseases 0.000 claims description 8
• 239000000539 dimer Substances 0.000 claims description 8
• 150000002632 lipids Chemical class 0.000 claims description 8
• 239000000463 material Substances 0.000 claims description 8
• 125000003729 nucleotide group Chemical group 0.000 claims description 8
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
• 206010069703 Bile acid malabsorption Diseases 0.000 claims description 7
• 206010009944 Colon cancer Diseases 0.000 claims description 7
• 230000008859 change Effects 0.000 claims description 7
• 239000000499 gel Substances 0.000 claims description 7
• 150000003839 salts Chemical class 0.000 claims description 7
• 238000003786 synthesis reaction Methods 0.000 claims description 7
• 206010016654 Fibrosis Diseases 0.000 claims description 6
• 208000002705 Glucose Intolerance Diseases 0.000 claims description 6
• 230000007882 cirrhosis Effects 0.000 claims description 6
• 230000001419 dependent effect Effects 0.000 claims description 6
• 238000011156 evaluation Methods 0.000 claims description 6
• 230000000670 limiting effect Effects 0.000 claims description 6
• 208000020816 lung neoplasm Diseases 0.000 claims description 6
• 230000000750 progressive effect Effects 0.000 claims description 6
• 208000010157 sclerosing cholangitis Diseases 0.000 claims description 6
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 6
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 5
• 208000011231 Crohn disease Diseases 0.000 claims description 5
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 5
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
• 241000159610 Roya <green alga> Species 0.000 claims description 5
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 5
• 238000002835 absorbance Methods 0.000 claims description 5
• 235000013405 beer Nutrition 0.000 claims description 5
• 229910052799 carbon Inorganic materials 0.000 claims description 5
• 208000009866 extrahepatic cholestasis Diseases 0.000 claims description 5
• 230000004153 glucose metabolism Effects 0.000 claims description 5
• 208000007232 portal hypertension Diseases 0.000 claims description 5
• 238000010257 thawing Methods 0.000 claims description 5
• 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 claims description 4
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
• 239000004471 Glycine Substances 0.000 claims description 4
• 241000764773 Inna Species 0.000 claims description 4
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
• 239000004472 Lysine Substances 0.000 claims description 4
• 206010056528 Neonatal cholestasis Diseases 0.000 claims description 4
• 244000000231 Sesamum indicum Species 0.000 claims description 4
• 241001424341 Tara spinosa Species 0.000 claims description 4
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 4
• 230000005856 abnormality Effects 0.000 claims description 4
• 239000002253 acid Substances 0.000 claims description 4
• 230000006835 compression Effects 0.000 claims description 4
• 238000007906 compression Methods 0.000 claims description 4
• 238000001962 electrophoresis Methods 0.000 claims description 4
• 208000019298 familial intrahepatic cholestasis Diseases 0.000 claims description 4
• 230000008014 freezing Effects 0.000 claims description 4
• 238000007710 freezing Methods 0.000 claims description 4
• 235000013922 glutamic acid Nutrition 0.000 claims description 4
• 239000004220 glutamic acid Substances 0.000 claims description 4
• 208000001024 intrahepatic cholestasis Diseases 0.000 claims description 4
• 238000007912 intraperitoneal administration Methods 0.000 claims description 4
• 150000002500 ions Chemical class 0.000 claims description 4
• 230000037356 lipid metabolism Effects 0.000 claims description 4
• 208000014018 liver neoplasm Diseases 0.000 claims description 4
• 230000004060 metabolic process Effects 0.000 claims description 4
• 239000000178 monomer Substances 0.000 claims description 4
• 230000002265 prevention Effects 0.000 claims description 4
• 238000002271 resection Methods 0.000 claims description 4
• 210000000813 small intestine Anatomy 0.000 claims description 4
• 238000007920 subcutaneous administration Methods 0.000 claims description 4
• 239000004475 Arginine Substances 0.000 claims description 3
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 3
• 206010004593 Bile duct cancer Diseases 0.000 claims description 3
• 241000283153 Cetacea Species 0.000 claims description 3
• 206010008609 Cholangitis sclerosing Diseases 0.000 claims description 3
• 235000003913 Coccoloba uvifera Nutrition 0.000 claims description 3
• 101100285518 Drosophila melanogaster how gene Proteins 0.000 claims description 3
• 108060003951 Immunoglobulin Proteins 0.000 claims description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 3
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 3
• 241000751119 Mila <angiosperm> Species 0.000 claims description 3
• 241000468053 Obodhiang virus Species 0.000 claims description 3
• 241001659863 Panna Species 0.000 claims description 3
• 241000549435 Pria Species 0.000 claims description 3
• 206010060862 Prostate cancer Diseases 0.000 claims description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 3
• 240000008976 Pterocarpus marsupium Species 0.000 claims description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 3
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
• 229940090047 auto-injector Drugs 0.000 claims description 3
• 208000026900 bile duct neoplasm Diseases 0.000 claims description 3
• 208000006990 cholangiocarcinoma Diseases 0.000 claims description 3
• 201000001883 cholelithiasis Diseases 0.000 claims description 3
• 230000035622 drinking Effects 0.000 claims description 3
• 208000001130 gallstones Diseases 0.000 claims description 3
• 208000004104 gestational diabetes Diseases 0.000 claims description 3
• 239000011521 glass Substances 0.000 claims description 3
• 102000018358 immunoglobulin Human genes 0.000 claims description 3
• 230000007872 intrahepatic cholestasis Effects 0.000 claims description 3
• 201000002161 intrahepatic cholestasis of pregnancy Diseases 0.000 claims description 3
• 238000007918 intramuscular administration Methods 0.000 claims description 3
• 229960000310 isoleucine Drugs 0.000 claims description 3
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
• 201000007270 liver cancer Diseases 0.000 claims description 3
• 230000033001 locomotion Effects 0.000 claims description 3
• 201000005202 lung cancer Diseases 0.000 claims description 3
• 208000037841 lung tumor Diseases 0.000 claims description 3
• 238000005259 measurement Methods 0.000 claims description 3
• 201000000742 primary sclerosing cholangitis Diseases 0.000 claims description 3
• 208000023958 prostate neoplasm Diseases 0.000 claims description 3
• 210000004243 sweat Anatomy 0.000 claims description 3
• 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
• 241001233887 Ania Species 0.000 claims description 2
• 206010003402 Arthropod sting Diseases 0.000 claims description 2
• OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 claims description 2
• 241000254173 Coleoptera Species 0.000 claims description 2
• 101100234002 Drosophila melanogaster Shal gene Proteins 0.000 claims description 2
• 241000102542 Kara Species 0.000 claims description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
• 241000286819 Malo Species 0.000 claims description 2
• 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 2
• 244000061176 Nicotiana tabacum Species 0.000 claims description 2
• 241000697033 Ostracion meleagris Species 0.000 claims description 2
• 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
• 235000011613 Pinus brutia Nutrition 0.000 claims description 2
• 241000018646 Pinus brutia Species 0.000 claims description 2
• 206010035148 Plague Diseases 0.000 claims description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
• 235000003976 Ruta Nutrition 0.000 claims description 2
• 240000005746 Ruta graveolens Species 0.000 claims description 2
• 235000015076 Shorea robusta Nutrition 0.000 claims description 2
• 244000166071 Shorea robusta Species 0.000 claims description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
• 239000004473 Threonine Substances 0.000 claims description 2
• 229910052770 Uranium Inorganic materials 0.000 claims description 2
• 241000607479 Yersinia pestis Species 0.000 claims description 2
• 206010000496 acne Diseases 0.000 claims description 2
• 235000004279 alanine Nutrition 0.000 claims description 2
• 235000009582 asparagine Nutrition 0.000 claims description 2
• 229960001230 asparagine Drugs 0.000 claims description 2
• 210000000941 bile Anatomy 0.000 claims description 2
• 230000015556 catabolic process Effects 0.000 claims description 2
• 238000006731 degradation reaction Methods 0.000 claims description 2
• 229920001971 elastomer Polymers 0.000 claims description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
• 230000036512 infertility Effects 0.000 claims description 2
• 230000007774 longterm Effects 0.000 claims description 2
• 229930182817 methionine Natural products 0.000 claims description 2
• HVAAHUDGWQAAOJ-UHFFFAOYSA-N n-benzylethanamine Chemical compound CCNCC1=CC=CC=C1 HVAAHUDGWQAAOJ-UHFFFAOYSA-N 0.000 claims description 2
• 229910052700 potassium Inorganic materials 0.000 claims description 2
• 239000005060 rubber Substances 0.000 claims description 2
• 235000005806 ruta Nutrition 0.000 claims description 2
• 210000002700 urine Anatomy 0.000 claims description 2
• 239000004474 valine Substances 0.000 claims description 2
• 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 claims 97
• 235000013550 pizza Nutrition 0.000 claims 26
• 101100460719 Mus musculus Noto gene Proteins 0.000 claims 16
• 101100187345 Xenopus laevis noto gene Proteins 0.000 claims 16
• 210000000720 eyelash Anatomy 0.000 claims 12
• 101150063042 NR0B1 gene Proteins 0.000 claims 8
• 235000013616 tea Nutrition 0.000 claims 8
• 244000269722 Thea sinensis Species 0.000 claims 7
• 239000013049 sediment Substances 0.000 claims 7
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
• 101100027969 Caenorhabditis elegans old-1 gene Proteins 0.000 claims 6
• 101100537311 Caenorhabditis elegans tkr-1 gene Proteins 0.000 claims 6
• 241000726103 Atta Species 0.000 claims 5
• 238000002474 experimental method Methods 0.000 claims 5
• 229940044765 k-phos Drugs 0.000 claims 4
• 238000011160 research Methods 0.000 claims 4
• 230000007958 sleep Effects 0.000 claims 4
• 238000011179 visual inspection Methods 0.000 claims 4
• 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims 3
• 240000008187 Erythrina edulis Species 0.000 claims 3
• 235000002757 Erythrina edulis Nutrition 0.000 claims 3
• 235000010469 Glycine max Nutrition 0.000 claims 3
• 241000283162 Inia geoffrensis Species 0.000 claims 3
• 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 claims 3
• 240000005481 Salvia hispanica Species 0.000 claims 3
• 235000001498 Salvia hispanica Nutrition 0.000 claims 3
• YLBMNMLHAAOXAL-UHFFFAOYSA-N aziv Chemical compound O1C(C)=C(O)C(=O)CC1OC1C2(C)CCC3(C)C4(C)CCC5C(C)(CO)C(OC6C(C(O)C(O)C(O6)C(O)=O)OC6C(C(O)C(O)C(CO)O6)OC6C(C(O)C(O)C(CO)O6)O)CCC5(C)C4CC=C3C2CC(C)(C)C1 YLBMNMLHAAOXAL-UHFFFAOYSA-N 0.000 claims 3
• JKKPSTXVKNWEAH-VWHZSNQBSA-N bbip Chemical compound NC(=N)NCCC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)C=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)CCC1 JKKPSTXVKNWEAH-VWHZSNQBSA-N 0.000 claims 3
• 244000275904 brauner Senf Species 0.000 claims 3
• 235000014167 chia Nutrition 0.000 claims 3
• JLESVLCTIOAHPT-UHFFFAOYSA-N mmai Chemical compound C1=C(C)C(OC)=CC2=C1CC(N)C2 JLESVLCTIOAHPT-UHFFFAOYSA-N 0.000 claims 3
• 239000002023 wood Substances 0.000 claims 3
• 241001182632 Akko Species 0.000 claims 2
• 101100495769 Caenorhabditis elegans che-1 gene Proteins 0.000 claims 2
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 claims 2
• 101100426970 Caenorhabditis elegans ttr-1 gene Proteins 0.000 claims 2
• 101100162296 Dictyostelium discoideum ahsa gene Proteins 0.000 claims 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 2
• 241001547860 Gaya Species 0.000 claims 2
• 244000068988 Glycine max Species 0.000 claims 2
• 240000007594 Oryza sativa Species 0.000 claims 2
• 241001377938 Yara Species 0.000 claims 2
• 230000002776 aggregation Effects 0.000 claims 2
• 238000004220 aggregation Methods 0.000 claims 2
• 229940030850 avar Drugs 0.000 claims 2
• 235000001159 dosh Nutrition 0.000 claims 2
• 244000245171 dosh Species 0.000 claims 2
• 239000000428 dust Substances 0.000 claims 2
• 230000035558 fertility Effects 0.000 claims 2
• 208000036260 idiopathic disease Diseases 0.000 claims 2
• 238000004007 reversed phase HPLC Methods 0.000 claims 2
• 230000002441 reversible effect Effects 0.000 claims 2
• FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 claims 1
• YQOUWOJPPGRPPW-UHFFFAOYSA-N 2-bis(4-methylphenyl)phosphanylethyl-bis(4-methylphenyl)phosphane Chemical compound C1=CC(C)=CC=C1P(C=1C=CC(C)=CC=1)CCP(C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 YQOUWOJPPGRPPW-UHFFFAOYSA-N 0.000 claims 1
• LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 claims 1
• 241001337993 Agathis <wasp> Species 0.000 claims 1
• 241000766754 Agra Species 0.000 claims 1
• 241000801941 Akania Species 0.000 claims 1
• 208000019901 Anxiety disease Diseases 0.000 claims 1
• 101100162210 Aspergillus parasiticus (strain ATCC 56775 / NRRL 5862 / SRRC 143 / SU-1) aflM gene Proteins 0.000 claims 1
• 241001206352 Bahaia Species 0.000 claims 1
• 241000486634 Bena Species 0.000 claims 1
• 206010061692 Benign muscle neoplasm Diseases 0.000 claims 1
• ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims 1
• RZZPDXZPRHQOCG-OJAKKHQRSA-N CDP-choline Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-N 0.000 claims 1
• 101150050673 CHK1 gene Proteins 0.000 claims 1
• 101100495768 Caenorhabditis elegans che-13 gene Proteins 0.000 claims 1
• 101100388509 Caenorhabditis elegans che-3 gene Proteins 0.000 claims 1
• 101100177348 Caenorhabditis elegans heh-1 gene Proteins 0.000 claims 1
• 101100182914 Caenorhabditis elegans mak-1 gene Proteins 0.000 claims 1
• 101100131052 Caenorhabditis elegans mog-1 gene Proteins 0.000 claims 1
• 101100425522 Caenorhabditis elegans mys-1 gene Proteins 0.000 claims 1
• 101100365746 Caenorhabditis elegans sid-5 gene Proteins 0.000 claims 1
• 101100102500 Caenorhabditis elegans ver-1 gene Proteins 0.000 claims 1
• 241000283707 Capra Species 0.000 claims 1
• 240000007681 Catha edulis Species 0.000 claims 1
• 235000006696 Catha edulis Nutrition 0.000 claims 1
• 240000000885 Citrullus colocynthis Species 0.000 claims 1
• 235000015844 Citrullus colocynthis Nutrition 0.000 claims 1
• 244000228088 Cola acuminata Species 0.000 claims 1
• 235000010205 Cola acuminata Nutrition 0.000 claims 1
• 235000015438 Cola nitida Nutrition 0.000 claims 1
• 206010010071 Coma Diseases 0.000 claims 1
• 241000632511 Daviesia arborea Species 0.000 claims 1
• 101100072303 Drosophila melanogaster IFT57 gene Proteins 0.000 claims 1
• 101100438361 Drosophila melanogaster capu gene Proteins 0.000 claims 1
• 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 claims 1
• 101150076104 EAT2 gene Proteins 0.000 claims 1
• 240000000731 Fagus sylvatica Species 0.000 claims 1
• 235000010099 Fagus sylvatica Nutrition 0.000 claims 1
• 241001572175 Gaza Species 0.000 claims 1
• 241000630665 Hada Species 0.000 claims 1
• 241000152447 Hades Species 0.000 claims 1
• 241000258937 Hemiptera Species 0.000 claims 1
• 101000589632 Homo sapiens N-acetylaspartate synthetase Proteins 0.000 claims 1
• 101000764625 Homo sapiens Transmembrane inner ear expressed protein Proteins 0.000 claims 1
• 102000008100 Human Serum Albumin Human genes 0.000 claims 1
• 108091006905 Human Serum Albumin Proteins 0.000 claims 1
• 244000071493 Iris tectorum Species 0.000 claims 1
• 241000557752 Khaya Species 0.000 claims 1
• 241000087799 Koma Species 0.000 claims 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
• 241000538132 Moya Species 0.000 claims 1
• 101100498160 Mus musculus Dach1 gene Proteins 0.000 claims 1
• 208000007101 Muscle Cramp Diseases 0.000 claims 1
• 201000004458 Myoma Diseases 0.000 claims 1
• 244000234179 Myrtus ugni Species 0.000 claims 1
• 235000012093 Myrtus ugni Nutrition 0.000 claims 1
• 102100032380 N-acetylaspartate synthetase Human genes 0.000 claims 1
• 241001602876 Nata Species 0.000 claims 1
• SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 claims 1
• 241000567149 Ochna serrulata Species 0.000 claims 1
• 241001079606 Paches Species 0.000 claims 1
• 241000282320 Panthera leo Species 0.000 claims 1
• 241000282376 Panthera tigris Species 0.000 claims 1
• 241001387976 Pera Species 0.000 claims 1
• 241000404883 Pisa Species 0.000 claims 1
• 101100149403 Rattus norvegicus Sh3rf2 gene Proteins 0.000 claims 1
• 241000555745 Sciuridae Species 0.000 claims 1
• 244000191761 Sida cordifolia Species 0.000 claims 1
• 244000258044 Solanum gilo Species 0.000 claims 1
• 235000018650 Solanum gilo Nutrition 0.000 claims 1
• 208000005392 Spasm Diseases 0.000 claims 1
• 241001128391 Taia Species 0.000 claims 1
• 241001648319 Toronia toru Species 0.000 claims 1
• 244000111306 Torreya nucifera Species 0.000 claims 1
• 235000006732 Torreya nucifera Nutrition 0.000 claims 1
• 102100026225 Transmembrane inner ear expressed protein Human genes 0.000 claims 1
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
• 241000289690 Xenarthra Species 0.000 claims 1
• 210000001015 abdomen Anatomy 0.000 claims 1
• MOVRNJGDXREIBM-UHFFFAOYSA-N aid-1 Chemical compound O=C1NC(=O)C(C)=CN1C1OC(COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)CO)C(O)C1 MOVRNJGDXREIBM-UHFFFAOYSA-N 0.000 claims 1
• 238000005349 anion exchange Methods 0.000 claims 1
• 230000003110 anti-inflammatory effect Effects 0.000 claims 1
• 238000012550 audit Methods 0.000 claims 1
• RVNOANDLZIIFHB-UHFFFAOYSA-N bhff Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC2=C1OC(=O)C2(O)C(F)(F)F RVNOANDLZIIFHB-UHFFFAOYSA-N 0.000 claims 1
• 229940098773 bovine serum albumin Drugs 0.000 claims 1
• 229940117702 breo Drugs 0.000 claims 1
• 235000021170 buffet Nutrition 0.000 claims 1
• 244000309464 bull Species 0.000 claims 1
• 125000004122 cyclic group Chemical group 0.000 claims 1
• 235000018417 cysteine Nutrition 0.000 claims 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
• 238000013461 design Methods 0.000 claims 1
• 238000000502 dialysis Methods 0.000 claims 1
• 150000004683 dihydrates Chemical class 0.000 claims 1
• PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 claims 1
• 238000011049 filling Methods 0.000 claims 1
• 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
• 239000003517 fume Substances 0.000 claims 1
• 230000008642 heat stress Effects 0.000 claims 1
• 210000003405 ileum Anatomy 0.000 claims 1
• 238000004255 ion exchange chromatography Methods 0.000 claims 1
• 238000011068 loading method Methods 0.000 claims 1
• 239000010413 mother solution Substances 0.000 claims 1
• 230000000474 nursing effect Effects 0.000 claims 1
• 244000144985 peep Species 0.000 claims 1
• IDOWTHOLJBTAFI-UHFFFAOYSA-N phenmedipham Chemical compound COC(=O)NC1=CC=CC(OC(=O)NC=2C=C(C)C=CC=2)=C1 IDOWTHOLJBTAFI-UHFFFAOYSA-N 0.000 claims 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
• 235000021178 picnic Nutrition 0.000 claims 1
• 238000003752 polymerase chain reaction Methods 0.000 claims 1
• 238000001556 precipitation Methods 0.000 claims 1
• FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 claims 1
• 238000012545 processing Methods 0.000 claims 1
• KNVAYBMMCPLDOZ-UHFFFAOYSA-N propan-2-yl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OC(C)C KNVAYBMMCPLDOZ-UHFFFAOYSA-N 0.000 claims 1
• 230000035945 sensitivity Effects 0.000 claims 1
• 230000036962 time dependent Effects 0.000 claims 1
• 239000008181 tonicity modifier Substances 0.000 claims 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
• 239000000052 vinegar Substances 0.000 claims 1
• 235000021419 vinegar Nutrition 0.000 claims 1
• 229940026385 zzip Drugs 0.000 claims 1
• 230000004927 fusion Effects 0.000 abstract description 22
• 239000002552 dosage form Substances 0.000 abstract description 18
• 239000000816 peptidomimetic Substances 0.000 abstract description 13
• 101710153349 Fibroblast growth factor 19 Proteins 0.000 abstract description 6
• 102000003973 Fibroblast growth factor 21 Human genes 0.000 abstract description 5
• 108090000376 Fibroblast growth factor 21 Proteins 0.000 abstract description 5
• 238000009472 formulation Methods 0.000 abstract 2
• 125000003275 alpha amino acid group Chemical group 0.000 description 467
• 238000006467 substitution reaction Methods 0.000 description 110
• 229920001184 polypeptide Polymers 0.000 description 64
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 54
• DPVHGFAJLZWDOC-PVXXTIHASA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol;dihydrate Chemical compound O.O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DPVHGFAJLZWDOC-PVXXTIHASA-N 0.000 description 43
• 229940074409 trehalose dihydrate Drugs 0.000 description 43
• 239000012634 fragment Substances 0.000 description 42
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 37
• -1 but not limited to Proteins 0.000 description 36
• 210000004899 c-terminal region Anatomy 0.000 description 35
• 108091006116 chimeric peptides Proteins 0.000 description 34
• 239000003795 chemical substances by application Substances 0.000 description 32
• LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 28
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 27
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 25
• 239000008103 glucose Substances 0.000 description 25
• 229940074410 trehalose Drugs 0.000 description 25
• 230000000875 corresponding effect Effects 0.000 description 24
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 24
• 235000002639 sodium chloride Nutrition 0.000 description 24
• 102000039446 nucleic acids Human genes 0.000 description 21
• 108020004707 nucleic acids Proteins 0.000 description 21
• 150000007523 nucleic acids Chemical class 0.000 description 21
• 241000282414 Homo sapiens Species 0.000 description 20
• 238000012217 deletion Methods 0.000 description 19
• 230000037430 deletion Effects 0.000 description 19
• 239000000047 product Substances 0.000 description 17
• 229910052757 nitrogen Chemical group 0.000 description 16
• 230000006870 function Effects 0.000 description 14
• 230000014509 gene expression Effects 0.000 description 14
• 229910000160 potassium phosphate Inorganic materials 0.000 description 14
• 235000011009 potassium phosphates Nutrition 0.000 description 14
• 238000003780 insertion Methods 0.000 description 13
• 230000037431 insertion Effects 0.000 description 13
• 102000004877 Insulin Human genes 0.000 description 12
• 108090001061 Insulin Proteins 0.000 description 12
• 229940125396 insulin Drugs 0.000 description 12
• 230000027455 binding Effects 0.000 description 10
• 210000004369 blood Anatomy 0.000 description 10
• 239000008280 blood Substances 0.000 description 10
• 239000003085 diluting agent Substances 0.000 description 10
• 229920005558 epichlorohydrin rubber Polymers 0.000 description 10
• 239000000725 suspension Substances 0.000 description 10
• 241001327708 Coriaria sarmentosa Species 0.000 description 9
• 239000004698 Polyethylene Substances 0.000 description 9
• CCAZWUJBLXKBAY-ULZPOIKGSA-N Tutin Chemical compound C([C@]12[C@@H]3O[C@@H]3[C@@]3(O)[C@H]4C(=O)O[C@@H]([C@H]([C@]32C)O)[C@H]4C(=C)C)O1 CCAZWUJBLXKBAY-ULZPOIKGSA-N 0.000 description 9
• 238000007792 addition Methods 0.000 description 9
• 229920001577 copolymer Polymers 0.000 description 9
• 239000002609 medium Substances 0.000 description 9
• 239000010979 ruby Substances 0.000 description 9
• 229910001750 ruby Inorganic materials 0.000 description 9
• 239000004480 active ingredient Substances 0.000 description 8
• 125000003277 amino group Chemical group 0.000 description 8
• 239000003112 inhibitor Substances 0.000 description 8
• 102000040430 polynucleotide Human genes 0.000 description 8
• 108091033319 polynucleotide Proteins 0.000 description 8
• 239000002157 polynucleotide Substances 0.000 description 8
• 239000000523 sample Substances 0.000 description 8
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 8
• 239000007787 solid Substances 0.000 description 8
• 239000000556 agonist Substances 0.000 description 7
• 239000002270 dispersing agent Substances 0.000 description 7
• 150000002148 esters Chemical class 0.000 description 7
• 201000001421 hyperglycemia Diseases 0.000 description 7
• 238000004519 manufacturing process Methods 0.000 description 7
• 210000002381 plasma Anatomy 0.000 description 7
• 229920001223 polyethylene glycol Polymers 0.000 description 7
• 239000002244 precipitate Substances 0.000 description 7
• 239000003755 preservative agent Substances 0.000 description 7
• 239000002904 solvent Substances 0.000 description 7
• 239000000375 suspending agent Substances 0.000 description 7
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
• 102100023006 Basic leucine zipper transcriptional factor ATF-like 2 Human genes 0.000 description 6
• 108020004414 DNA Proteins 0.000 description 6
• 102000053602 DNA Human genes 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 108010010234 HDL Lipoproteins Proteins 0.000 description 6
• 102000015779 HDL Lipoproteins Human genes 0.000 description 6
• 101000903615 Homo sapiens Basic leucine zipper transcriptional factor ATF-like 2 Proteins 0.000 description 6
• 239000002202 Polyethylene glycol Substances 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 150000004665 fatty acids Chemical group 0.000 description 6
• 239000000825 pharmaceutical preparation Substances 0.000 description 6
• 239000003826 tablet Substances 0.000 description 6
• 230000001225 therapeutic effect Effects 0.000 description 6
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
• 244000005894 Albizia lebbeck Species 0.000 description 5
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 5
• 239000005977 Ethylene Substances 0.000 description 5
• IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 208000008589 Obesity Diseases 0.000 description 5
• 150000001408 amides Chemical class 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 210000004027 cell Anatomy 0.000 description 5
• 239000007859 condensation product Substances 0.000 description 5
• 230000003111 delayed effect Effects 0.000 description 5
• 235000014113 dietary fatty acids Nutrition 0.000 description 5
• 239000000839 emulsion Substances 0.000 description 5
• 239000000194 fatty acid Substances 0.000 description 5
• 229930195729 fatty acid Natural products 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 5
• 238000007911 parenteral administration Methods 0.000 description 5
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
• 239000011734 sodium Substances 0.000 description 5
• 125000001424 substituent group Chemical group 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 238000012384 transportation and delivery Methods 0.000 description 5
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
• 229960000281 trometamol Drugs 0.000 description 5
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
• 108020004635 Complementary DNA Proteins 0.000 description 4
• 108010010803 Gelatin Proteins 0.000 description 4
• 108010007622 LDL Lipoproteins Proteins 0.000 description 4
• 102000007330 LDL Lipoproteins Human genes 0.000 description 4
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 4
• 206010033307 Overweight Diseases 0.000 description 4
• 235000019483 Peanut oil Nutrition 0.000 description 4
• 241000514450 Podocarpus latifolius Species 0.000 description 4
• 108010077895 Sarcosine Proteins 0.000 description 4
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
• 241000750042 Vini Species 0.000 description 4
• 125000000217 alkyl group Chemical group 0.000 description 4
• 230000037396 body weight Effects 0.000 description 4
• 238000010804 cDNA synthesis Methods 0.000 description 4
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
• 239000003995 emulsifying agent Substances 0.000 description 4
• 239000008273 gelatin Substances 0.000 description 4
• 229920000159 gelatin Polymers 0.000 description 4
• 235000019322 gelatine Nutrition 0.000 description 4
• 235000011852 gelatine desserts Nutrition 0.000 description 4
• 230000010030 glucose lowering effect Effects 0.000 description 4
• 238000006206 glycosylation reaction Methods 0.000 description 4
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
• 239000002502 liposome Substances 0.000 description 4
• 210000004185 liver Anatomy 0.000 description 4
• 235000020824 obesity Nutrition 0.000 description 4
• 239000004006 olive oil Substances 0.000 description 4
• 235000008390 olive oil Nutrition 0.000 description 4
• 230000036961 partial effect Effects 0.000 description 4
• 239000000312 peanut oil Substances 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 229920000139 polyethylene terephthalate Polymers 0.000 description 4
• 239000005020 polyethylene terephthalate Substances 0.000 description 4
• 229940043230 sarcosine Drugs 0.000 description 4
• 239000000080 wetting agent Substances 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 3
• 244000215068 Acacia senegal Species 0.000 description 3
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
• 102000009027 Albumins Human genes 0.000 description 3
• 108010088751 Albumins Proteins 0.000 description 3
• 101100049050 Arabidopsis thaliana PVA41 gene Proteins 0.000 description 3
• 201000001320 Atherosclerosis Diseases 0.000 description 3
• 241000543381 Cliftonia monophylla Species 0.000 description 3
• 108091026890 Coding region Proteins 0.000 description 3
• 229920000858 Cyclodextrin Polymers 0.000 description 3
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
• 208000032928 Dyslipidaemia Diseases 0.000 description 3
• 229920000084 Gum arabic Polymers 0.000 description 3
• 241001026509 Kata Species 0.000 description 3
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
• 108091028043 Nucleic acid sequence Proteins 0.000 description 3
• 229920002367 Polyisobutene Polymers 0.000 description 3
• 241000036848 Porzana carolina Species 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 235000010489 acacia gum Nutrition 0.000 description 3
• 239000000205 acacia gum Substances 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 239000004599 antimicrobial Substances 0.000 description 3
• 239000003963 antioxidant agent Substances 0.000 description 3
• 235000006708 antioxidants Nutrition 0.000 description 3
• 239000007900 aqueous suspension Substances 0.000 description 3
• 235000010323 ascorbic acid Nutrition 0.000 description 3
• 239000011668 ascorbic acid Substances 0.000 description 3
• 229960005070 ascorbic acid Drugs 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 150000001576 beta-amino acids Chemical class 0.000 description 3
• 210000003995 blood forming stem cell Anatomy 0.000 description 3
• 150000001721 carbon Chemical group 0.000 description 3
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
• 239000001768 carboxy methyl cellulose Substances 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 238000001212 derivatisation Methods 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 235000011187 glycerol Nutrition 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 239000000017 hydrogel Substances 0.000 description 3
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
• 239000007943 implant Substances 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 206010021654 increased appetite Diseases 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
• 239000000693 micelle Substances 0.000 description 3
• 239000003094 microcapsule Substances 0.000 description 3
• 230000003278 mimic effect Effects 0.000 description 3
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 235000019198 oils Nutrition 0.000 description 3
• 235000019271 petrolatum Nutrition 0.000 description 3
• 229940124531 pharmaceutical excipient Drugs 0.000 description 3
• 201000010065 polycystic ovary syndrome Diseases 0.000 description 3
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
• 201000009104 prediabetes syndrome Diseases 0.000 description 3
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 229920002477 rna polymer Polymers 0.000 description 3
• 235000019640 taste Nutrition 0.000 description 3
• 239000002562 thickening agent Substances 0.000 description 3
• 239000010936 titanium Substances 0.000 description 3
• 150000003626 triacylglycerols Chemical class 0.000 description 3
• 235000015112 vegetable and seed oil Nutrition 0.000 description 3
• 239000008158 vegetable oil Substances 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
• IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
• ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
• PBLZLIFKVPJDCO-UHFFFAOYSA-N 12-aminododecanoic acid Chemical compound NCCCCCCCCCCCC(O)=O PBLZLIFKVPJDCO-UHFFFAOYSA-N 0.000 description 2
• 150000003923 2,5-pyrrolediones Chemical class 0.000 description 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
• 241000566113 Branta sandvicensis Species 0.000 description 2
• 208000005623 Carcinogenesis Diseases 0.000 description 2
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
• ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
• 239000001116 FEMA 4028 Substances 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
• 101000578774 Homo sapiens MAP kinase-activated protein kinase 5 Proteins 0.000 description 2
• 206010020772 Hypertension Diseases 0.000 description 2
• 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 2
• 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 2
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• 208000017170 Lipid metabolism disease Diseases 0.000 description 2
• 102100028396 MAP kinase-activated protein kinase 5 Human genes 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
• WJXSXWBOZMVFPJ-NENRSDFPSA-N N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-methoxy-2,4-dimethyloxan-3-yl]-N-methylacetamide Chemical compound CO[C@@H]1O[C@H](C)[C@@H](N(C)C(C)=O)[C@@](C)(O)[C@@H]1O WJXSXWBOZMVFPJ-NENRSDFPSA-N 0.000 description 2
• RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 239000005062 Polybutadiene Substances 0.000 description 2
• 208000001280 Prediabetic State Diseases 0.000 description 2
• 201000001718 Roberts syndrome Diseases 0.000 description 2
• 208000012474 Roberts-SC phocomelia syndrome Diseases 0.000 description 2
• 241000718541 Tetragastris balsamifera Species 0.000 description 2
• 229920001615 Tragacanth Polymers 0.000 description 2
• XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 150000001371 alpha-amino acids Chemical class 0.000 description 2
• 239000003708 ampul Substances 0.000 description 2
• 239000012736 aqueous medium Substances 0.000 description 2
• 125000003118 aryl group Chemical group 0.000 description 2
• 235000003704 aspartic acid Nutrition 0.000 description 2
• 208000006673 asthma Diseases 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
• WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
• 229960004853 betadex Drugs 0.000 description 2
• 230000001588 bifunctional effect Effects 0.000 description 2
• 239000007975 buffered saline Substances 0.000 description 2
• 229910000019 calcium carbonate Inorganic materials 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 230000036952 cancer formation Effects 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 231100000504 carcinogenesis Toxicity 0.000 description 2
• 239000002738 chelating agent Substances 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 229960004926 chlorobutanol Drugs 0.000 description 2
• 229960002173 citrulline Drugs 0.000 description 2
• 235000013477 citrulline Nutrition 0.000 description 2
• 239000003240 coconut oil Substances 0.000 description 2
• 235000019864 coconut oil Nutrition 0.000 description 2
• 239000008139 complexing agent Substances 0.000 description 2
• 238000013270 controlled release Methods 0.000 description 2
• 239000003431 cross linking reagent Substances 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 2
• 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
• 208000037765 diseases and disorders Diseases 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 229940011871 estrogen Drugs 0.000 description 2
• 239000000262 estrogen Substances 0.000 description 2
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 229940125753 fibrate Drugs 0.000 description 2
• 235000003599 food sweetener Nutrition 0.000 description 2
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
• 210000001035 gastrointestinal tract Anatomy 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 229940075507 glyceryl monostearate Drugs 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
• 229940072221 immunoglobulins Drugs 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 239000012535 impurity Substances 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 238000007917 intracranial administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 239000007951 isotonicity adjuster Substances 0.000 description 2
• OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical group OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 239000004310 lactic acid Substances 0.000 description 2
• 235000014655 lactic acid Nutrition 0.000 description 2
• 125000005647 linker group Chemical group 0.000 description 2
• 239000003589 local anesthetic agent Substances 0.000 description 2
• 229960005015 local anesthetics Drugs 0.000 description 2
• 239000008176 lyophilized powder Substances 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
• 229920000609 methyl cellulose Polymers 0.000 description 2
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
• 235000010981 methylcellulose Nutrition 0.000 description 2
• 239000001923 methylcellulose Substances 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 239000004005 microsphere Substances 0.000 description 2
• 239000002480 mineral oil Substances 0.000 description 2
• 235000010446 mineral oil Nutrition 0.000 description 2
• 108091005601 modified peptides Proteins 0.000 description 2
• GHLZUHZBBNDWHW-UHFFFAOYSA-N nonanamide Chemical compound CCCCCCCCC(N)=O GHLZUHZBBNDWHW-UHFFFAOYSA-N 0.000 description 2
• 239000012457 nonaqueous media Substances 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 239000000346 nonvolatile oil Substances 0.000 description 2
• 239000012053 oil suspension Substances 0.000 description 2
• 230000008520 organization Effects 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000005022 packaging material Substances 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 239000002504 physiological saline solution Substances 0.000 description 2
• 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
• 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
• 229920000573 polyethylene Polymers 0.000 description 2
• 239000004926 polymethyl methacrylate Substances 0.000 description 2
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
• 229920000053 polysorbate 80 Polymers 0.000 description 2
• 230000008092 positive effect Effects 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• 125000006239 protecting group Chemical group 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 239000003352 sequestering agent Substances 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 239000008159 sesame oil Substances 0.000 description 2
• 235000011803 sesame oil Nutrition 0.000 description 2
• 229920002379 silicone rubber Polymers 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• 235000011069 sorbitan monooleate Nutrition 0.000 description 2
• 239000001593 sorbitan monooleate Substances 0.000 description 2
• 229940035049 sorbitan monooleate Drugs 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
• 229940033663 thimerosal Drugs 0.000 description 2
• 150000003573 thiols Chemical class 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 239000013598 vector Substances 0.000 description 2
• 239000008215 water for injection Substances 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
• FXYPGCIGRDZWNR-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-[[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSCCC(=O)ON1C(=O)CCC1=O FXYPGCIGRDZWNR-UHFFFAOYSA-N 0.000 description 1
• NMDDZEVVQDPECF-LURJTMIESA-N (2s)-2,7-diaminoheptanoic acid Chemical compound NCCCCC[C@H](N)C(O)=O NMDDZEVVQDPECF-LURJTMIESA-N 0.000 description 1
• PECGVEGMRUZOML-AWEZNQCLSA-N (2s)-2-amino-3,3-diphenylpropanoic acid Chemical compound C=1C=CC=CC=1C([C@H](N)C(O)=O)C1=CC=CC=C1 PECGVEGMRUZOML-AWEZNQCLSA-N 0.000 description 1
• LPBSHGLDBQBSPI-YFKPBYRVSA-N (2s)-2-amino-4,4-dimethylpentanoic acid Chemical compound CC(C)(C)C[C@H](N)C(O)=O LPBSHGLDBQBSPI-YFKPBYRVSA-N 0.000 description 1
• YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
• BLRBOMBBUUGKFU-SREVYHEPSA-N (z)-4-[[4-(4-chlorophenyl)-5-(2-methoxy-2-oxoethyl)-1,3-thiazol-2-yl]amino]-4-oxobut-2-enoic acid Chemical compound S1C(NC(=O)\C=C/C(O)=O)=NC(C=2C=CC(Cl)=CC=2)=C1CC(=O)OC BLRBOMBBUUGKFU-SREVYHEPSA-N 0.000 description 1
• ICLYJLBTOGPLMC-KVVVOXFISA-N (z)-octadec-9-enoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O ICLYJLBTOGPLMC-KVVVOXFISA-N 0.000 description 1
• UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
• BQIFCAGMUAMYDV-DHBOJHSNSA-N 1-(2-chloroethyl)-3-[(2r,6s)-2,6-dihydroxycyclohexyl]-1-nitrosourea Chemical compound O[C@H]1CCC[C@@H](O)C1NC(=O)N(CCCl)N=O BQIFCAGMUAMYDV-DHBOJHSNSA-N 0.000 description 1
• PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• ODMMNALOCMNQJZ-UHFFFAOYSA-N 1H-pyrrolizine Chemical compound C1=CC=C2CC=CN21 ODMMNALOCMNQJZ-UHFFFAOYSA-N 0.000 description 1
• BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 description 1
• SKWCZPYWFRTSDD-UHFFFAOYSA-N 2,3-bis(azaniumyl)propanoate;chloride Chemical compound Cl.NCC(N)C(O)=O SKWCZPYWFRTSDD-UHFFFAOYSA-N 0.000 description 1
• OFKFBEJYOHXPIA-UHFFFAOYSA-N 2,3-dihydro-1h-isoindol-2-ium-1-carboxylate Chemical compound C1=CC=C2C(C(=O)O)NCC2=C1 OFKFBEJYOHXPIA-UHFFFAOYSA-N 0.000 description 1
• UKUVVAMSXXBMRX-UHFFFAOYSA-N 2,4,5-trithia-1,3-diarsabicyclo[1.1.1]pentane Chemical compound S1[As]2S[As]1S2 UKUVVAMSXXBMRX-UHFFFAOYSA-N 0.000 description 1
• OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
• DXMQZKIEVHKNTN-UHFFFAOYSA-N 2-[carbamimidoyl(ethyl)amino]acetic acid Chemical compound CCN(C(N)=N)CC(O)=O DXMQZKIEVHKNTN-UHFFFAOYSA-N 0.000 description 1
• LKZQHZQXROBVOO-UHFFFAOYSA-N 2-amino-2-methylhexanoic acid Chemical compound CCCCC(C)(N)C(O)=O LKZQHZQXROBVOO-UHFFFAOYSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• BIGBDMFRWJRLGJ-UHFFFAOYSA-N 3-benzyl-1,5-didiazoniopenta-1,4-diene-2,4-diolate Chemical compound [N-]=[N+]=CC(=O)C(C(=O)C=[N+]=[N-])CC1=CC=CC=C1 BIGBDMFRWJRLGJ-UHFFFAOYSA-N 0.000 description 1
• 101710168795 3-oxoacyl-[acyl-carrier-protein] synthase 1 Proteins 0.000 description 1
• 101710158551 3-oxoacyl-[acyl-carrier-protein] synthase I, chloroplastic Proteins 0.000 description 1
• SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 description 1
• NLPWSMKACWGINL-UHFFFAOYSA-N 4-azido-2-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(N=[N+]=[N-])C=C1O NLPWSMKACWGINL-UHFFFAOYSA-N 0.000 description 1
• UPALIKSFLSVKIS-UHFFFAOYSA-N 5-amino-2-[2-(dimethylamino)ethyl]benzo[de]isoquinoline-1,3-dione Chemical compound NC1=CC(C(N(CCN(C)C)C2=O)=O)=C3C2=CC=CC3=C1 UPALIKSFLSVKIS-UHFFFAOYSA-N 0.000 description 1
• SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
• UQXNEWQGGVUVQA-UHFFFAOYSA-N 8-aminooctanoic acid Chemical compound NCCCCCCCC(O)=O UQXNEWQGGVUVQA-UHFFFAOYSA-N 0.000 description 1
• YPMOAQISONSSNL-UHFFFAOYSA-N 8-hydroxyoctyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCO YPMOAQISONSSNL-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 206010000234 Abortion spontaneous Diseases 0.000 description 1
• 241000238876 Acari Species 0.000 description 1
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
• 241001116389 Aloe Species 0.000 description 1
• 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
• 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 235000007119 Ananas comosus Nutrition 0.000 description 1
• 244000099147 Ananas comosus Species 0.000 description 1
• 206010002942 Apathy Diseases 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 235000007319 Avena orientalis Nutrition 0.000 description 1
• 244000075850 Avena orientalis Species 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 235000017491 Bambusa tulda Nutrition 0.000 description 1
• 244000218454 Bambusa tulda Species 0.000 description 1
• 241001211977 Bida Species 0.000 description 1
• 229940123208 Biguanide Drugs 0.000 description 1
• XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
• 241000283725 Bos Species 0.000 description 1
• 235000011293 Brassica napus Nutrition 0.000 description 1
• 240000002791 Brassica napus Species 0.000 description 1
• 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
• 101800001415 Bri23 peptide Proteins 0.000 description 1
• 101800000655 C-terminal peptide Proteins 0.000 description 1
• 102400000107 C-terminal peptide Human genes 0.000 description 1
• 101100426956 Caenorhabditis elegans ttn-1 gene Proteins 0.000 description 1
• 235000017399 Caesalpinia tinctoria Nutrition 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 206010007749 Cataract diabetic Diseases 0.000 description 1
• 241000282994 Cervidae Species 0.000 description 1
• 241000905957 Channa melasoma Species 0.000 description 1
• 239000004709 Chlorinated polyethylene Substances 0.000 description 1
• UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 description 1
• 241001338801 Chlorus Species 0.000 description 1
• 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
• 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
• 240000000560 Citrus x paradisi Species 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 235000004257 Cordia myxa Nutrition 0.000 description 1
• 244000157795 Cordia myxa Species 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 244000304337 Cuminum cyminum Species 0.000 description 1
• 235000007129 Cuminum cyminum Nutrition 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• 241000283014 Dama Species 0.000 description 1
• 208000016192 Demyelinating disease Diseases 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 208000008960 Diabetic foot Diseases 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• 101001014194 Dictyostelium discoideum Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 description 1
• QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
• 235000011511 Diospyros Nutrition 0.000 description 1
• 241000723267 Diospyros Species 0.000 description 1
• MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 241000792859 Enema Species 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
• 241000238558 Eucarida Species 0.000 description 1
• 241001553148 Euphorbia degeneri Species 0.000 description 1
• 239000001653 FEMA 3120 Substances 0.000 description 1
• 206010048474 Fat redistribution Diseases 0.000 description 1
• JHJOOSLFWRRSGU-UHFFFAOYSA-N Fenchlorphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(Cl)C=C1Cl JHJOOSLFWRRSGU-UHFFFAOYSA-N 0.000 description 1
• 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 1
• 101710182387 Fibroblast growth factor receptor 4 Proteins 0.000 description 1
• 235000008730 Ficus carica Nutrition 0.000 description 1
• 244000025361 Ficus carica Species 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 102000001267 GSK3 Human genes 0.000 description 1
• 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 206010018473 Glycosuria Diseases 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 241000581652 Hagenia abyssinica Species 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 235000015854 Heliotropium curassavicum Nutrition 0.000 description 1
• 244000301682 Heliotropium curassavicum Species 0.000 description 1
• 244000043261 Hevea brasiliensis Species 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101001013796 Homo sapiens Metallothionein-1M Proteins 0.000 description 1
• 101000730368 Homo sapiens Phosducin Proteins 0.000 description 1
• 101000654674 Homo sapiens Semaphorin-6A Proteins 0.000 description 1
• 206010020710 Hyperphagia Diseases 0.000 description 1
• 229940122199 Insulin secretagogue Drugs 0.000 description 1
• 208000035478 Interatrial communication Diseases 0.000 description 1
• 238000012695 Interfacial polymerization Methods 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
• ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
• FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
• JTTHKOPSMAVJFE-VIFPVBQESA-N L-homophenylalanine Chemical compound OC(=O)[C@@H](N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-VIFPVBQESA-N 0.000 description 1
• UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
• QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 description 1
• UCUNFLYVYCGDHP-BYPYZUCNSA-N L-methionine sulfone Chemical compound CS(=O)(=O)CC[C@H](N)C(O)=O UCUNFLYVYCGDHP-BYPYZUCNSA-N 0.000 description 1
• QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 241000288903 Lemuridae Species 0.000 description 1
• 241001124569 Lycaenidae Species 0.000 description 1
• 244000241872 Lycium chinense Species 0.000 description 1
• 206010025476 Malabsorption Diseases 0.000 description 1
• 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
• 241001446467 Mama Species 0.000 description 1
• 241001214257 Mene Species 0.000 description 1
• 102100031783 Metallothionein-1M Human genes 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 241000408551 Meza Species 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• 229920003354 Modic® Polymers 0.000 description 1
• 241000357437 Mola Species 0.000 description 1
• 241001077660 Molo Species 0.000 description 1
• 241001206439 Motya Species 0.000 description 1
• 101100440233 Mus musculus Cmpk2 gene Proteins 0.000 description 1
• 101100064676 Mus musculus Edem1 gene Proteins 0.000 description 1
• 101100338513 Mus musculus Hdac9 gene Proteins 0.000 description 1
• 101100425017 Mus musculus Qtrt1 gene Proteins 0.000 description 1
• 240000005561 Musa balbisiana Species 0.000 description 1
• 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
• 102100038750 Myc-associated zinc finger protein Human genes 0.000 description 1
• 101710146400 Myc-associated zinc finger protein Proteins 0.000 description 1
• 241000207439 Myra Species 0.000 description 1
• FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
• 241001611408 Nebo Species 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 208000007301 Night Eating Syndrome Diseases 0.000 description 1
• 241000849798 Nita Species 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 241000283965 Ochotona princeps Species 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 239000008896 Opium Substances 0.000 description 1
• 208000005141 Otitis Diseases 0.000 description 1
• 241000531207 Oxera splendida Species 0.000 description 1
• 235000019482 Palm oil Nutrition 0.000 description 1
• 235000008753 Papaver somniferum Nutrition 0.000 description 1
• 241000218180 Papaveraceae Species 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 238000007205 Parnes methylation reaction Methods 0.000 description 1
• 241000429017 Pectis Species 0.000 description 1
• CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
• 102100032600 Phosducin Human genes 0.000 description 1
• 240000005546 Piper methysticum Species 0.000 description 1
• 235000016787 Piper methysticum Nutrition 0.000 description 1
• 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
• 102000007327 Protamines Human genes 0.000 description 1
• 108010007568 Protamines Proteins 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 241001313871 Puma Species 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 241000022563 Rema Species 0.000 description 1
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
• 208000025747 Rheumatic disease Diseases 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 239000008156 Ringer's lactate solution Substances 0.000 description 1
• 235000019485 Safflower oil Nutrition 0.000 description 1
• 102100032795 Semaphorin-6A Human genes 0.000 description 1
• 206010040007 Sense of oppression Diseases 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 206010049416 Short-bowel syndrome Diseases 0.000 description 1
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
• DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
• 206010041349 Somnolence Diseases 0.000 description 1
• 241001575049 Sonia Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 241001599630 Stelis <bee> Species 0.000 description 1
• 241001415849 Strigiformes Species 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 229940100389 Sulfonylurea Drugs 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 241001655798 Taku Species 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 235000009470 Theobroma cacao Nutrition 0.000 description 1
• 244000299461 Theobroma cacao Species 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 241000656145 Thyrsites atun Species 0.000 description 1
• 241001130469 Tila Species 0.000 description 1
• RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
• 241000838698 Togo Species 0.000 description 1
• GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 241000270506 Tupinambis Species 0.000 description 1
• BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 101100338514 Xenopus laevis hdac9 gene Proteins 0.000 description 1
• 235000004552 Yucca aloifolia Nutrition 0.000 description 1
• 235000012044 Yucca brevifolia Nutrition 0.000 description 1
• 235000017049 Yucca glauca Nutrition 0.000 description 1
• 240000005780 Yucca gloriosa Species 0.000 description 1
• 241000405115 Zela Species 0.000 description 1
• 241000079527 Ziziphus spina-christi Species 0.000 description 1
• WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
• 230000003187 abdominal effect Effects 0.000 description 1
• 235000011054 acetic acid Nutrition 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
• 239000011149 active material Substances 0.000 description 1
• 239000008186 active pharmaceutical agent Substances 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 210000000577 adipose tissue Anatomy 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 150000001335 aliphatic alkanes Chemical class 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000002947 alkylene group Chemical group 0.000 description 1
• 235000011399 aloe vera Nutrition 0.000 description 1
• 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
• 235000008206 alpha-amino acids Nutrition 0.000 description 1
• HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
• 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000003862 amino acid derivatives Chemical class 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 208000022531 anorexia Diseases 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000002788 anti-peptide Effects 0.000 description 1
• 238000011091 antibody purification Methods 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 238000011225 antiretroviral therapy Methods 0.000 description 1
• 239000012062 aqueous buffer Substances 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 125000003710 aryl alkyl group Chemical group 0.000 description 1
• 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
• 239000000305 astragalus gummifer gum Substances 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• 206010003664 atrial septal defect Diseases 0.000 description 1
• 229960002170 azathioprine Drugs 0.000 description 1
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
• 230000003385 bacteriostatic effect Effects 0.000 description 1
• 235000013527 bean curd Nutrition 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• 229960001950 benzethonium chloride Drugs 0.000 description 1
• UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
• 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
• 235000013361 beverage Nutrition 0.000 description 1
• 229920000080 bile acid sequestrant Polymers 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 238000007413 biotinylation Methods 0.000 description 1
• 230000006287 biotinylation Effects 0.000 description 1
• JCZLABDVDPYLRZ-AWEZNQCLSA-N biphenylalanine Chemical compound C1=CC(C[C@H](N)C(O)=O)=CC=C1C1=CC=CC=C1 JCZLABDVDPYLRZ-AWEZNQCLSA-N 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 239000004067 bulking agent Substances 0.000 description 1
• DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 229920005549 butyl rubber Polymers 0.000 description 1
• 244000240602 cacao Species 0.000 description 1
• 235000010216 calcium carbonate Nutrition 0.000 description 1
• 125000001314 canonical amino-acid group Chemical group 0.000 description 1
• 230000023852 carbohydrate metabolic process Effects 0.000 description 1
• 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
• 125000004432 carbon atom Chemical group C* 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 238000012219 cassette mutagenesis Methods 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 235000019438 castor oil Nutrition 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 208000026106 cerebrovascular disease Diseases 0.000 description 1
• 229960000541 cetyl alcohol Drugs 0.000 description 1
• 230000001587 cholestatic effect Effects 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 101150116749 chuk gene Proteins 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 235000015165 citric acid Nutrition 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000005354 coacervation Methods 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 229960001338 colchicine Drugs 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000001246 colloidal dispersion Methods 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 230000009137 competitive binding Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 208000029078 coronary artery disease Diseases 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 150000001896 cresols Chemical class 0.000 description 1
• 239000002577 cryoprotective agent Substances 0.000 description 1
• 125000004093 cyano group Chemical group *C#N 0.000 description 1
• 229940097362 cyclodextrins Drugs 0.000 description 1
• 229930182912 cyclosporin Natural products 0.000 description 1
• 230000006240 deamidation Effects 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 210000004268 dentin Anatomy 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 235000021185 dessert Nutrition 0.000 description 1
• 239000008355 dextrose injection Substances 0.000 description 1
• 201000007025 diabetic cataract Diseases 0.000 description 1
• 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 1
• JNSGIVNNHKGGRU-JYRVWZFOSA-N diethoxyphosphinothioyl (2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetate Chemical compound CCOP(=S)(OCC)OC(=O)C(=N/OC)\C1=CSC(N)=N1 JNSGIVNNHKGGRU-JYRVWZFOSA-N 0.000 description 1
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 208000016097 disease of metabolism Diseases 0.000 description 1
• 239000002612 dispersion medium Substances 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 125000004119 disulfanediyl group Chemical group *SS* 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 229940088679 drug related substance Drugs 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 208000019258 ear infection Diseases 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 239000007920 enema Substances 0.000 description 1
• 229940095399 enema Drugs 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 201000000421 erythematosquamous dermatosis Diseases 0.000 description 1
• HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• 125000001033 ether group Chemical group 0.000 description 1
• 239000005038 ethylene vinyl acetate Substances 0.000 description 1
• PHTXVQQRWJXYPP-UHFFFAOYSA-N ethyltrifluoromethylaminoindane Chemical compound C1=C(C(F)(F)F)C=C2CC(NCC)CC2=C1 PHTXVQQRWJXYPP-UHFFFAOYSA-N 0.000 description 1
• 231100000040 eye damage Toxicity 0.000 description 1
• 210000004709 eyebrow Anatomy 0.000 description 1
• 210000000887 face Anatomy 0.000 description 1
• 201000003373 familial cold autoinflammatory syndrome 3 Diseases 0.000 description 1
• OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 235000021323 fish oil Nutrition 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 229920001821 foam rubber Polymers 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 230000001408 fungistatic effect Effects 0.000 description 1
• ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
• 239000010437 gem Substances 0.000 description 1
• 229910001751 gemstone Inorganic materials 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 230000014101 glucose homeostasis Effects 0.000 description 1
• 208000018914 glucose metabolism disease Diseases 0.000 description 1
• 238000007446 glucose tolerance test Methods 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
• 230000002641 glycemic effect Effects 0.000 description 1
• ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
• 229940074045 glyceryl distearate Drugs 0.000 description 1
• 229940075529 glyceryl stearate Drugs 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 229920000591 gum Polymers 0.000 description 1
• 229910052736 halogen Inorganic materials 0.000 description 1
• 150000002367 halogens Chemical class 0.000 description 1
• 239000007902 hard capsule Substances 0.000 description 1
• 230000003862 health status Effects 0.000 description 1
• 208000024798 heartburn Diseases 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• CBCIHIVRDWLAME-UHFFFAOYSA-N hexanitrodiphenylamine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O CBCIHIVRDWLAME-UHFFFAOYSA-N 0.000 description 1
• 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 239000008173 hydrogenated soybean oil Substances 0.000 description 1
• 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
• 229920001477 hydrophilic polymer Polymers 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
• 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
• 230000002267 hypothalamic effect Effects 0.000 description 1
• 150000002463 imidates Chemical class 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000002584 immunomodulator Effects 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 229910052738 indium Inorganic materials 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 229940102213 injectable suspension Drugs 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 206010022437 insomnia Diseases 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000007915 intraurethral administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 150000003951 lactams Chemical class 0.000 description 1
• JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
• 150000002596 lactones Chemical class 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 239000008297 liquid dosage form Substances 0.000 description 1
• 238000012317 liver biopsy Methods 0.000 description 1
• AVDXUVZURBFCNE-UHFFFAOYSA-N lolin Natural products CC1C(O)C(O)C2(COC(=O)C)C(CCC=C2CO)C13CC(OC3=O)c4cocc4 AVDXUVZURBFCNE-UHFFFAOYSA-N 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 239000012907 medicinal substance Substances 0.000 description 1
• 229940057917 medium chain triglycerides Drugs 0.000 description 1
• 229950004994 meglitinide Drugs 0.000 description 1
• 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 208000015994 miscarriage Diseases 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• MATYBIXNDNXYMI-UHFFFAOYSA-N n-(2-oxopropyl)-n-prop-2-enylnitrous amide Chemical compound CC(=O)CN(N=O)CC=C MATYBIXNDNXYMI-UHFFFAOYSA-N 0.000 description 1
• 239000002088 nanocapsule Substances 0.000 description 1
• 239000002071 nanotube Substances 0.000 description 1
• 229920003052 natural elastomer Polymers 0.000 description 1
• 229920001206 natural gum Polymers 0.000 description 1
• 229920001194 natural rubber Polymers 0.000 description 1
• 229910052754 neon Inorganic materials 0.000 description 1
• GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 230000003959 neuroinflammation Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• 231100000344 non-irritating Toxicity 0.000 description 1
• 230000009871 nonspecific binding Effects 0.000 description 1
• 235000014571 nuts Nutrition 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
• 239000007764 o/w emulsion Substances 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
• 208000017920 oculo-auriculo-vertebral spectrum Diseases 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 229960001027 opium Drugs 0.000 description 1
• 238000007410 oral glucose tolerance test Methods 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 108010014561 ovomucoid inhibitors Proteins 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 238000001139 pH measurement Methods 0.000 description 1
• 239000002540 palm oil Substances 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 235000010603 pastilles Nutrition 0.000 description 1
• 239000011049 pearl Substances 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 235000019477 peppermint oil Nutrition 0.000 description 1
• 210000001428 peripheral nervous system Anatomy 0.000 description 1
• 208000027232 peripheral nervous system disease Diseases 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• 150000002989 phenols Chemical class 0.000 description 1
• YKWNDAOEJQMLGH-UHFFFAOYSA-N phenyl 2,2-diphenylacetate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)C(=O)OC1=CC=CC=C1 YKWNDAOEJQMLGH-UHFFFAOYSA-N 0.000 description 1
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
• 235000011007 phosphoric acid Nutrition 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical group O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 description 1
• 125000004193 piperazinyl group Chemical group 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 229920001308 poly(aminoacid) Polymers 0.000 description 1
• 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
• 229920001084 poly(chloroprene) Polymers 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 229920002857 polybutadiene Polymers 0.000 description 1
• 229920000728 polyester Polymers 0.000 description 1
• 239000008389 polyethoxylated castor oil Substances 0.000 description 1
• 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
• 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
• 239000004633 polyglycolic acid Substances 0.000 description 1
• 229920001195 polyisoprene Polymers 0.000 description 1
• 229920005597 polymer membrane Polymers 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 210000004896 polypeptide structure Anatomy 0.000 description 1
• 208000022530 polyphagia Diseases 0.000 description 1
• 239000011118 polyvinyl acetate Substances 0.000 description 1
• 229920002689 polyvinyl acetate Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 229920000915 polyvinyl chloride Polymers 0.000 description 1
• 239000004800 polyvinyl chloride Substances 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 239000013615 primer Substances 0.000 description 1
• 239000002987 primer (paints) Substances 0.000 description 1
• 229960001309 procaine hydrochloride Drugs 0.000 description 1
• 229940002612 prodrug Drugs 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• 208000037821 progressive disease Diseases 0.000 description 1
• 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
• 229950008679 protamine sulfate Drugs 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• MXRGZXBFSKSZPH-UHFFFAOYSA-N protheobromine Chemical compound O=C1N(CC(O)C)C(=O)N(C)C2=C1N(C)C=N2 MXRGZXBFSKSZPH-UHFFFAOYSA-N 0.000 description 1
• 230000003331 prothrombotic effect Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 238000011158 quantitative evaluation Methods 0.000 description 1
• 238000000163 radioactive labelling Methods 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 229910052761 rare earth metal Inorganic materials 0.000 description 1
• 239000008175 ready-to-use sterile solution Substances 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000000979 retarding effect Effects 0.000 description 1
• 230000033764 rhythmic process Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 235000005713 safflower oil Nutrition 0.000 description 1
• 239000003813 safflower oil Substances 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
• 238000009958 sewing Methods 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
• 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
• 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 239000008354 sodium chloride injection Substances 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
• 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
• 229940001584 sodium metabisulfite Drugs 0.000 description 1
• 235000010262 sodium metabisulphite Nutrition 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 239000002195 soluble material Substances 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 235000014347 soups Nutrition 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• 239000008347 soybean phospholipid Substances 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 208000000995 spontaneous abortion Diseases 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 238000005556 structure-activity relationship Methods 0.000 description 1
• 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 description 1
• YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 229920001897 terpolymer Polymers 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 150000003568 thioethers Chemical class 0.000 description 1
• 230000009974 thixotropic effect Effects 0.000 description 1
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 201000005665 thrombophilia Diseases 0.000 description 1
• 229910052719 titanium Inorganic materials 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
• 229940117013 triethanolamine oleate Drugs 0.000 description 1
• HADKRTWCOYPCPH-UHFFFAOYSA-M trimethylphenylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C1=CC=CC=C1 HADKRTWCOYPCPH-UHFFFAOYSA-M 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 235000019583 umami taste Nutrition 0.000 description 1
• 229920011532 unplasticized polyvinyl chloride Polymers 0.000 description 1
• 210000003708 urethra Anatomy 0.000 description 1
• 150000007968 uric acids Chemical class 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000001215 vagina Anatomy 0.000 description 1
• 229910052720 vanadium Inorganic materials 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 230000003313 weakening effect Effects 0.000 description 1
• 235000019786 weight gain Nutrition 0.000 description 1
• 230000036642 wellbeing Effects 0.000 description 1
• 235000014101 wine Nutrition 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 229940126158 β3 adrenergic receptor agonist Drugs 0.000 description 1